Vestbo J - Search Results

1

Characterisation of COPD heterogeneity in the ECLIPSE cohort.

Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Agusti A, et al. Among authors: vestbo j. Respir Res. 2010 Sep 10;11(1):122. doi: 10.1186/1465-9921-11-122. Respir Res. 2010. PMID: 20831787 Free PMC article. Clinical Trial.

2

Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys.

Müllerová H, Wedzicha J, Soriano JB, Vestbo J. Müllerová H, et al. Among authors: vestbo j. Respir Med. 2004 Jan;98(1):78-83. doi: 10.1016/j.rmed.2003.08.009. Respir Med. 2004. PMID: 14959817 Free article.

3

Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD.

Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P; TRISTAN Study Group. Vestbo J, et al. Respir Med. 2004 Nov;98(11):1045-50. doi: 10.1016/j.rmed.2004.03.017. Respir Med. 2004. PMID: 15526804 Free article. Clinical Trial.

4

Gender differences in the management and experience of Chronic Obstructive Pulmonary Disease.

Watson L, Vestbo J, Postma DS, Decramer M, Rennard S, Kiri VA, Vermeire PA, Soriano JB. Watson L, et al. Among authors: vestbo j. Respir Med. 2004 Dec;98(12):1207-13. doi: 10.1016/j.rmed.2004.05.004. Respir Med. 2004. PMID: 15588042 Free article.

5

COPD: the dangerous underestimate of 15%.

Rennard SI, Vestbo J. Rennard SI, et al. Among authors: vestbo j. Lancet. 2006 Apr 15;367(9518):1216-9. doi: 10.1016/S0140-6736(06)68516-4. Lancet. 2006. PMID: 16631861 No abstract available.

6

Improving the care of COPD patients - suggested action points by the COPD exacerbations taskforce for reducing the burden of exacerbations of COPD.

Celli B, Cross S, Grossman R, Kardos P, Myrseth SE, Rodriguez-Roisin R, Vestbo J. Celli B, et al. Among authors: vestbo j. Prim Care Respir J. 2006 Jun;15(3):139-42. doi: 10.1016/j.pcrj.2006.02.008. Epub 2006 Mar 30. Prim Care Respir J. 2006. PMID: 16757393 Free PMC article. No abstract available.

7

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators. Calverley PM, et al. Among authors: vestbo j. N Engl J Med. 2007 Feb 22;356(8):775-89. doi: 10.1056/NEJMoa063070. N Engl J Med. 2007. PMID: 17314337 Free article. Clinical Trial.

8

A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.

Soriano JB, Sin DD, Zhang X, Camp PG, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Petersson S, Postma DS, Szafranski W, Vestbo J. Soriano JB, et al. Among authors: vestbo j. Chest. 2007 Mar;131(3):682-689. doi: 10.1378/chest.06-1696. Chest. 2007. PMID: 17356080

9

CD4-regulatory cells in COPD patients.

Smyth LJ, Starkey C, Vestbo J, Singh D. Smyth LJ, et al. Among authors: vestbo j. Chest. 2007 Jul;132(1):156-63. doi: 10.1378/chest.07-0083. Epub 2007 May 15. Chest. 2007. PMID: 17505034

10

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM. Celli BR, et al. Among authors: vestbo j. Am J Respir Crit Care Med. 2008 Aug 15;178(4):332-8. doi: 10.1164/rccm.200712-1869OC. Epub 2008 May 29. Am J Respir Crit Care Med. 2008. PMID: 18511702 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters